Syam Sundar Mukharjee Madivada

Syam Sundar Mukharjee Madivada

Active Director Director DIN 07183706
DIN 07183706 First appointment Apr 2016 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Apr 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Syam Sundar Mukharjee Madivada

Data last updated:

Syam Sundar Mukharjee Madivada is a Director at Katzung Pharmaceuticals Private Limited (since 2017), Designated Partner at Pulse Heart Super Speciality Hospital Llp (since 2023) and Director at Power Consent Solutions Private Limited (since 2020). The companies operate in Pharma, Healthcare and Business Outsourcing. The largest current company by reported revenue is Katzung Pharmaceuticals Private Limited at ₹6.17 Cr (FY 2024). Earlier, Syam Sundar Mukharjee Madivada was a Director at Sahrudaya Health Care Private Limited (2016–2020) and Director at Wilson Morris Enterprises Private Limited (from 2017).

DIN 07183706
Primary Designation Director
Industry Pharma
First Appointment 02 Apr 2016
Oldest Company Age 9 yrs
Largest company Katzung Pharmaceuticals Private Limited Β· ₹6.17 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jun 20172017₹6.17 Cr (FY 2024)Active
Designated Partner11 Jan 20232023Active
Director20 Nov 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Apr 20162011₹1,837 Cr (FY 2025)Active
Director24 Jun 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Wilson Morris Enterprises Private Limited
Katzung Pharmaceuticals Private Limited
Power Consent Solutions Private Limited
Pulse Heart Super Speciality Hospital Llp
Premium access

Shareholding and investment profile for Syam Sundar Mukharjee Madivada

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Syam Sundar Mukharjee Madivada

Syam Sundar Mukharjee Madivada currently holds 3 directorships: Katzung Pharmaceuticals Private Limited (Director, since 27 Jun 2017, revenue β‚Ή6.17 Cr (FY 2024)); Pulse Heart Super Speciality Hospital Llp (Designated Partner, since 11 Jan 2023); Power Consent Solutions Private Limited (Director, since 20 Nov 2020).

Syam Sundar Mukharjee Madivada was first appointed on 02 Apr 2016 as Director at Sahrudaya Health Care Private Limited. The most recent appointment on record is 11 Jan 2023 at Pulse Heart Super Speciality Hospital Llp.

Syam Sundar Mukharjee Madivada held 2 earlier board appointments: Sahrudaya Health Care Private Limited (Director, 02 Apr 2016 to 15 May 2020); Wilson Morris Enterprises Private Limited (Director, from 24 Jun 2017).

The current boards of Syam Sundar Mukharjee Madivada's companies include Amar Vennapusa (Katzung Pharmaceuticals Private Limited), Kranthi Kumar Chintala (Katzung Pharmaceuticals Private Limited), Mahesh Babu Jambuladinne (Katzung Pharmaceuticals Private Limited), Narasimha Raj Mandapati (Power Consent Solutions Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available